Propionibacterium aenesas a causative agent of sarcoidosis
Propionibacterium aenesas a causative agent of sarcoidosis
批准号:
14370195
负责人:
EISHI Yoshinobu
金额:
$7.94万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
病因不明的结节病可能是由于遗传易感对象暴露于特定的环境病原体(S),可能是传染性病原体,尽管尚未发现任何病原体。痤疮丙酸杆菌是迄今为止从结节病损中分离到的唯一细菌。用定量聚合酶链式反应在结节状淋巴结中检测到大量痤疮螺旋体的基因组。通过原位杂交,在肉芽肿内及周围的结节状淋巴结内发现了痤疮病毒基因组。这些结果指出痤疮和一些结节病之间的病因学联系。重组痤疮触发因子蛋白(RP35)在一些结节病患者中引起细胞免疫反应,但在非结节病患者中不能。RP35在一些用该蛋白和佐剂致敏的小鼠中会导致肺颗粒细胞增多。痤疮P是周围肺组织和纵隔淋巴结最常见的固有细菌,这可能是这些器官经常发生结节病的原因。结节样肉芽肿可能是由免疫系统遗传性或获得性异常的个体对一种或多种痤疮假单胞菌抗原的Th1免疫反应而形成的,这些抗原在受影响的器官中原发或增殖。
英文摘要
Sarcoidosis, of unknown etiology, may result from exposure of a genetically susceptible subject to a specific enviromnental agent(s), possibly an infectious one, although none has been identified. Propionibacterium acnes is so far the only bacterium to be isolated from sarcoid lesions. Many genomes of P acnes have been detected in sarcoid lymph nodes by the quantitative polymerase chain reaction. By in situ hybridization, P acnes genomes were found in sarcoid lymph nodes in and around sarcoid granulomas. These results point to an etiological link between P acnes and some cases of sarcoidosis. A recombinant triggerfactor protein (RP35) from P acnes causes a cellular immune response in some patients with sarcoidosis, but not in subjects without sarcoidosis. RP35 causes pulmonary granuloinas in some of the mice sensitized with the protein and adjuvant. P acnes is the most common bacterium indigenous to the peripheral lung tissues and mediastinal lymph nodes, which may be the reason why these organs are so frequently involved in sarcoidosis. Sarcoid granulomas may be formed by a Th1 immune response to one or more antigens of P. acnes indigenous to or proliferating in the affected organs in an individual with a hereditary or acquired abnormality of the immune system.
期刊论文(72)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yamada T, Eishi Y, Ikeda S, et al.: "In sit localization of Propionibacterium acnes DSN in lymph nodes from sarcodosis patients by signal amplification with catalysed reporter deposition."Journal of Pathology. 198. 541-547 (2002)
Yamada T、Eishi Y、Ikeda S 等人:“通过信号放大和催化报告沉积,在结节病患者的淋巴结中对痤疮丙酸杆菌 DSN 进行原位定位。”病理学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
江石義信: "Annual Review 2003(サルコイドーシスとP.acnes)"中外医学社. 270 (2003)
Yoshinobu Eishi:“2003 年年度回顾(结节病和痤疮丙酸杆菌)”Chugai Igakusha。270 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
江石義信: "呼吸器疾患-state of arts 2003-2005(編集、北村, 福地, 石井)"医歯薬出版株式会社. 815 (2003)
Yoshinobu Eishi:“呼吸系统疾病 - 2003-2005 年的最新进展(北村、福地、石井编辑)”石药出版有限公司 815(2003 年)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamada T, et al.: "In situ localization of Propionibacterium acnes DNA in lymph nodes from sarcoidosis patients by signal amplification with catalyzed reporter deposition."J Pathol. 198. 541-547 (2002)
Yamada T 等人:“通过信号放大和催化报告沉积,对结节病患者淋巴结中的痤疮丙酸杆菌 DNA 进行原位定位。”J Pathol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kobayashi D, Eishi Y, Ohkusa T, et al.: "Gastric mucosal density of Helicobacter pylonri estimated by real-time PCR compared with results of urea breath test and histological grading"Journal of Medical Microbiology. 51. 1-7 (2002)
Kobayashi D、Eishi Y、Ohkusa T 等人:“通过实时 PCR 估算的幽门螺杆菌胃粘膜密度与尿素呼气试验和组织学分级结果的比较”《医学微生物学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 35 条
The establishment of new screening method using the secretory protein expression system for the investigation of the causative antigen of the disease mainly composed cell-mediated immune response.
-
批准号:24659402
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2012
-
负责人:EISHI Yoshinobu
-
依托单位:
Correlation between inflammation-associated carcinogenesis and ectopic expression of activation-induced cytidine deaminase in prostatic epithelial cells
-
批准号:22659287
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.09万
-
财政年份:2010
-
负责人:EISHI Yoshinobu
-
依托单位:
オートファジーによる細胞内感染防御システムと肉芽腫形成機構
-
批准号:18390112
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.87万
-
财政年份:2006
-
负责人:EISHI Yoshinobu
-
依托单位: